Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Late Systolic Myocardial Loading Is Associated With Left Atrial Dysfunction in Hypertension.

Chirinos JA, Phan TS, Syed AA, Hashmath Z, Oldland HG, Koppula MR, Tariq A, Javaid K, Miller R, Varakantam S, Dunde A, Neetha V, Akers SR.

Circ Cardiovasc Imaging. 2017 Jun;10(6):e006023. doi: 10.1161/CIRCIMAGING.116.006023.

PMID:
28592592
3.

Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis.

Singla S, Zhou T, Javaid K, Abbasi T, Casanova N, Zhang W, Ma SF, Wade MS, Noth I, Sweiss NJ, Garcia JG, Machado RF.

Pulm Circ. 2016 Dec;6(4):465-471. doi: 10.1086/688316.

4.

Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts.

Zarei A, Morovat A, Javaid K, Brown CP.

Bone Res. 2016 Oct 11;4:16030. eCollection 2016.

5.

A concise synthesis and evaluation of new malonamide derivatives as potential α-glucosidase inhibitors.

Islam MS, Barakat A, Al-Majid AM, Ghabbour HA, Rahman AF, Javaid K, Imad R, Yousuf S, Choudhary MI.

Bioorg Med Chem. 2016 Apr 15;24(8):1675-82. doi: 10.1016/j.bmc.2016.02.037. Epub 2016 Mar 2.

PMID:
26972921
6.

Ultrasonic synthesis of tyramine derivatives as novel inhibitors of α-glucosidase in vitro.

Siddiqui H, Bashir MA, Javaid K, Nizamani A, Bano H, Yousuf S, Rahman AU, Choudhary MI.

J Enzyme Inhib Med Chem. 2016 Dec;31(6):1392-403. doi: 10.3109/14756366.2016.1142983. Epub 2016 Feb 25.

PMID:
26912275
7.

Dihydropyrano [2,3-c] pyrazole: Novel in vitro inhibitors of yeast α-glucosidase.

Kashtoh H, Muhammad MT, Khan JJ, Rasheed S, Khan A, Perveen S, Javaid K, Atia-Tul-Wahab, Khan KM, Choudhary MI.

Bioorg Chem. 2016 Apr;65:61-72. doi: 10.1016/j.bioorg.2016.01.008. Epub 2016 Feb 1.

PMID:
26874344
8.

New α-glucosidase inhibiting anthracenone from the barks of Harungana madagascariensis Lam.

Onajobi IB, Adhikari A, Hussain S, Javaid K, Fagade OE, Oladosu IA.

Nat Prod Res. 2015 Nov 30:1-7. [Epub ahead of print]

PMID:
26621758
9.

2-Arylquinazolin-4(3H)-ones: A new class of α-glucosidase inhibitors.

Javaid K, Saad SM, Rasheed S, Moin ST, Syed N, Fatima I, Salar U, Khan KM, Perveen S, Choudhary MI.

Bioorg Med Chem. 2015 Dec 1;23(23):7417-21. doi: 10.1016/j.bmc.2015.10.038. Epub 2015 Oct 29. Erratum in: Bioorg Med Chem. 2015 Dec 15;23(24):7786.

PMID:
26552899
10.

Evaluation of 2-indolcarbohydrazones as potent α-glucosidase inhibitors, in silico studies and DFT based stereochemical predictions.

Taha M, Ismail NH, Javaid K, Imran S, Anouar el H, Wadood A, Atia-Tul-Wahab, Ali M, Khan KM, Saad SM, Rahim F, Choudhary MI.

Bioorg Chem. 2015 Dec;63:24-35. doi: 10.1016/j.bioorg.2015.09.001. Epub 2015 Sep 10.

PMID:
26398141
11.

Erratum to: Taxonomy of rare genetic metabolic bone disorders.

Masi L, Agnusdei D, Bilezikian J, Chappard D, Chapurlat R, Cianferotti L, Devolgelaer JP, El Maghraoui A, Ferrari S, Javaid K, Kaufman JM, Liberman UA, Lyritis G, Miller P, Napoli N, Roldan E, Papapoulos S, Watts NB, Brandi ML.

Osteoporos Int. 2015 Nov;26(11):2717-8. doi: 10.1007/s00198-015-3237-4. No abstract available.

PMID:
26370825
12.

Protocols and Hospital Mortality in Critically Ill Patients: The United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study.

Sevransky JE, Checkley W, Herrera P, Pickering BW, Barr J, Brown SM, Chang SY, Chong D, Kaufman D, Fremont RD, Girard TD, Hoag J, Johnson SB, Kerlin MP, Liebler J, O'Brien J, O'Keefe T, Park PK, Pastores SM, Patil N, Pietropaoli AP, Putman M, Rice TW, Rotello L, Siner J, Sajid S, Murphy DJ, Martin GS; United States Critical Illness and Injury Trials Group-Critical Illness Outcomes Study Investigators.

Crit Care Med. 2015 Oct;43(10):2076-84. doi: 10.1097/CCM.0000000000001157.

PMID:
26110488
13.

Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

Armbrecht G, Felsenberg D, Ganswindt M, Lunt M, Kaptoge SK, Abendroth K, Aroso A, Banzer D, Bhalla AK, Dequeker J, Eastell R, Hoszowski K, Lyritis G, Delmas PD, Masaryk P, Miazgowski T, Cannata J, Nuti R, Oei L, Poor G, Redlund-Johnell I, Reid DM, Reisinger W, Schatz H, Todd CJ, Woolf AD, Javaid K, Rivadeneira F, Silman AJ, Cooper C, O'Neill TW, Reeve J; European Vertebral Osteoporosis Study and European Prospective Osteoporosis Study Groups.

Osteoporos Int. 2015 Oct;26(10):2509-19. doi: 10.1007/s00198-015-3170-6. Epub 2015 May 29.

PMID:
26021761
14.

Immune mechanisms in type-2 diabetic retinopathy.

Afzal N, Zaman S, Shahzad F, Javaid K, Zafar A, Nagi AH.

J Pak Med Assoc. 2015 Feb;65(2):159-63.

PMID:
25842551
15.

Where does ergometrine stand in prevention of postpartum haemorrhage in caesarean section?

Mahmud G, Javaid K, Tasnim N, Tabassum A, Bangash KT.

J Pak Med Assoc. 2014 Aug;64(8):911-4.

16.

Enumeration of CD4(+)CD25(+)T regulatory cells in Type-II diabetes retinopathy.

Afzal N, Javaid K, Zaman S, Zafar A, Nagi AH.

Pak J Pharm Sci. 2014 Sep;27(5):1191-7.

PMID:
25176359
17.

Vitamin D supplementation in pregnancy: a systematic review.

Harvey NC, Holroyd C, Ntani G, Javaid K, Cooper P, Moon R, Cole Z, Tinati T, Godfrey K, Dennison E, Bishop NJ, Baird J, Cooper C.

Health Technol Assess. 2014 Jul;18(45):1-190. doi: 10.3310/hta18450. Review.

18.
19.

Inverse relationship of serum IL-17 with type-II diabetes retinopathy.

Nadeem A, Javaid K, Sami W, Zafar A, Jahan S, Zaman S, Nagi A.

Clin Lab. 2013;59(11-12):1311-7.

PMID:
24409666
20.

Supplemental Content

Loading ...
Support Center